Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Anti-oxidative Effect of Ligustrazine on Treatment and Prevention of Atherosclerosis

Gui-dong Huang, Jian Mao , Zhong-wei Ji

State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, PR China;

For correspondence:- Jian Mao Email: maojiand417@163.com Tel:+8651085329062

Received: 11 July 2013 Accepted: 24 October 2013 Published: 24 December 2013

Citation: Huang G, Mao J, Ji Z. Anti-oxidative Effect of Ligustrazine on Treatment and Prevention of Atherosclerosis. Trop J Pharm Res 2013; 12(6):949-957 doi: 10.4314/tjpr.v12i6.13

© 2013 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the protective effects of ligustrazine on oxidative stress-induced atherosclerosis.

Methods: The indicators related to oxidative stress were determined using commercially available assay kits. MTT assay was used to assess the survival rate of human umbilical vein endothelial cells (HUVECs). HUVECs apoptosis was analyzed using fluorescence staining and flow cytometry. mRNA expression level and activity of caspases 3, 8, and 9 were determined via quantitative real-time polymerase chain reaction (PCR) and caspase 3, 8, and 9 assay kits.

Results: Ligustrazine concentration of < 80 µmol/L had negligible inhibitory effect on HUVECs viability and protected HUVECs against oxygen stress damage by regulating the indicators related to oxidative stress. Flow cytometry results show that ligustrazine ameliorated H₂O₂-induced apoptosis, while the proportion of cells that stepped into early apoptosis and late apoptosis or necrosis were 52.7 and 0.6 %, respectively, in the H₂O₂ group, and 38.2 and 1.3 %, respectively, in the ligustrazine group. In addition, ligustrazine attenuated the up-regulation of caspase 3, 8, and 9 mRNA expression levels and activity.

Conclusion: Ligustrazine can protect HUVECs against H₂O₂-induced injuries by regulating the indicators related to oxidative stress and suppressing the overexpression of caspases 3, 8, and 9. The protective mechanism of ligustrazine on H₂O₂-induced injury in HUVECs may be a caspase-dependent anti-apoptotic mechanism which provide important information for treating and preventing oxidative stress-induced atherosclerosis.

Keywords: Ligustrazine, Oxidative stress, Umbilical vein, Endothelial cells, Atherosclerosis